1-2 of 2
Slaheddine Fattoum
Close
Sort by
Journal Articles

Iron chelation with deferasirox in adult and pediatric patients with thalassemia major: efficacy and safety during 5 years' follow-up

Clinical Trials & Observations
M. Domenica Cappellini, Mohamed Bejaoui, Leyla Agaoglu, Duran Canatan, Marcello Capra, Alan Cohen, Guillermo Drelichman, Marina Economou, Slaheddine Fattoum, Antonis Kattamis, Yurdanur Kilinc, Silverio Perrotta, Antonio Piga, John B. Porter, Louis Griffel, Victor Dong, Joan Clark, Yesim Aydinok
Journal: Blood
Blood (2011) 118 (4): 884–893.
https://doi.org/10.1182/blood-2010-11-316646
Published: 2011
Includes: Supplemental data
Journal Articles

A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with β-thalassemia

Clinical Trials & Observations
Maria Domenica Cappellini, Alan Cohen, Antonio Piga, Mohamed Bejaoui, Silverio Perrotta, Leyla Agaoglu, Yesim Aydinok, Antonis Kattamis, Yurdanur Kilinc, John Porter, Marcello Capra, Renzo Galanello, Slaheddine Fattoum, Guillermo Drelichman, Carmelo Magnano, Monica Verissimo, Miranda Athanassiou-Metaxa, Patricia Giardina, Alexandra Kourakli-Symeonidis, Gritta Janka-Schaub, Thomas Coates, Christiane Vermylen, Nancy Olivieri, Isabelle Thuret, Herbert Opitz, Catherine Ressayre-Djaffer, Peter Marks, Daniele Alberti
Journal: Blood
Blood (2006) 107 (9): 3455–3462.
https://doi.org/10.1182/blood-2005-08-3430
Published: 2006